Aveanna Healthcare (NASDAQ:AVAH) Insider Sells $948,750.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 125,000 shares of the stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. This trade represents a 37.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Aveanna Healthcare Stock Down 4.4%

NASDAQ AVAH opened at $7.33 on Friday. The firm has a market cap of $1.60 billion, a PE ratio of 6.21, a price-to-earnings-growth ratio of 0.87 and a beta of 1.93. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The stock’s 50 day simple moving average is $6.75 and its 200 day simple moving average is $7.85. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s revenue for the quarter was up 15.9% on a year-over-year basis. As a group, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.56 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

A number of institutional investors have recently bought and sold shares of AVAH. AustralianSuper Pty Ltd acquired a new stake in Aveanna Healthcare during the 3rd quarter worth $15,743,000. Vanguard Group Inc. grew its holdings in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after acquiring an additional 1,535,351 shares during the period. Millennium Management LLC grew its holdings in Aveanna Healthcare by 1,007.1% during the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after acquiring an additional 1,014,030 shares during the period. Nuveen LLC grew its holdings in Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after acquiring an additional 905,316 shares during the period. Finally, Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the 3rd quarter worth $7,922,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th. Truist Financial raised their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a report on Friday, March 20th. Finally, BMO Capital Markets lowered their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $10.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.